IFNA1 and hepatitis C virus infection: Current standard treatment of hepatitis C consists of the nucleoside analog ribavirin, which blocks guanine nucleotide synthesis, in combination with PEGylated interferon (IFN)-α, which activates the IFN-mediated antiviral response4.